isoproterenol has been researched along with enoximone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobowski, G; Bristol, JA; Duell, BL; Evans, DB; Sircar, I | 1 |
| Dage, RC; Grisar, JM; Schnettler, RA | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bethke, T; Eschenhagen, T; Klimkiewicz, A; Kohl, C; Mehl, H; Mende, U; Meyer, W; Neumann, J; Rosswag, S; von der Leyen, H | 1 |
| Gilbert, EM; Hershberger, RE; Lee, HR; Mealey, PC; Menlove, R; O'Connell, JB; Port, JD; Rasmussen, R; Renlund, DG; Volkman, K | 1 |
| Endoh, M | 1 |
| Leier, CV | 1 |
| Vaughan Williams, EM | 1 |
| van Meel, JC | 1 |
| Baim, DS | 1 |
| Kelso, EJ; McDermott, BJ; Silke, B | 1 |
| Katircioglu, SF; Saritas, Z; Ulus, AT; Yamak, B | 1 |
| Hackmann, F; Hellige, G; Hoebel, D; Luers, F; Pfahlberg, A; Rizouli, V; Schiffmann, H | 1 |
15 other study(ies) available for isoproterenol and enoximone
| Article | Year |
|---|---|
Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Chemical Phenomena; Chemistry, Physical; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Pyridazines; Structure-Activity Relationship | 1985 |
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Chemical Phenomena; Chemistry; Dogs; Female; Heart Rate; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Pentobarbital; Propranolol | 1982 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts.
Topics: Adult; Cardiomyopathies; Chromatography, DEAE-Cellulose; Enoximone; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain; Phosphodiesterase Inhibitors | 1992 |
Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Topics: Adult; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Catecholamines; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Imidazoles; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Myocardium; Receptors, Adrenergic, beta; Survival Rate | 1991 |
Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism.
Topics: Animals; Calcium; Carbachol; Colforsin; Cyclic AMP; Dogs; Enoximone; Female; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Receptors, Muscarinic | 1989 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
Is phosphodiesterase inhibition arrhythmogenic? Electrophysiologic effects in pithed rats and in normoxic and hypoxic rabbit atria of enoximone, a new cardiotonic agent.
Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Decerebrate State; Electrophysiology; Enoximone; Heart Rate; Imidazoles; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Oxygen; Phosphodiesterase Inhibitors; Rabbits; Rats | 1987 |
Comparison of some new positive inotropic agents in guinea pigs.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Dose-Response Relationship, Drug; Enoximone; Guinea Pigs; Heart Rate; Hydralazine; Imidazoles; Isoproterenol; Male; Myocardial Contraction; Ouabain; Vasodilation | 1985 |
Effects of amrinone on myocardial energetics in severe congestive heart failure.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Dogs; Enoximone; Heart; Heart Failure; Humans; Imidazoles; Isoproterenol; Milrinone; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones | 1985 |
Differential effects of phosphodiesterase inhibitors on accumulation of cyclic AMP in isolated ventricular cardiomyocytes.
Topics: Animals; Cells, Cultured; Colforsin; Cyclic AMP; Enoximone; Imidazoles; Isoenzymes; Isoproterenol; Male; Myocardium; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridines; Rats; Rats, Sprague-Dawley | 1995 |
Comparison of the effects of enoximone and isoproterenol on protamine cardiotoxicity in anesthetized dogs.
Topics: Animals; Cardiotonic Agents; Dogs; Drug Interactions; Enoximone; Heart; Heparin Antagonists; Isoproterenol; Protamines; Thoracic Surgical Procedures; Ventricular Function, Left | 1998 |
Na(+)-channel modulation, a new principle of inotropic intervention: effects on hemodynamic and myocardial energetics in the immature rabbit heart.
Topics: Age Factors; Animals; Animals, Newborn; Azetidines; Cardiotonic Agents; Coronary Circulation; Cyclic AMP; Enoximone; Female; Isoproterenol; Models, Cardiovascular; Myocardial Contraction; Myocardium; Ouabain; Oxygen Consumption; Pregnancy; Rabbits; Sodium Channels | 2003 |